Faster recovery of leukocytes due to haemopoietic growth factor in patients with chemotherapy-related granulocytopenia and fever, but no shortened hospital stay;Sneller herstel van leukocyten door hematopoetische groeifactor bij patienten met door chemotherapie veroorzaakte granulocytopenie en koorts, maar geen kortere opnameduur

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 32, 1996, Pages 1650-1655

  Vellenga, E ^a   Uyl De Groot, C A ^b   Stoter, G ^c   Lowenberg B ^c   De Vries, E G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; PLACEBO; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; GRANULOCYTOPENIA; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; NEUTROPHIL; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030055918     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
2. Pizzo PA. Granulocytopenia and cancer therapy Past problems, current solutions, future challenges. Cancer 1984;54(11 Suppl):2649-61.
3. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 1992;327:28-35.
4. Hoekman K, Wagstaff J, Ossenkoppele GJ, Pinedo HM. De toe-passing van hematopoëtische groeifactoren in de oncologie. Ned Tijdschr Geneeskd 1991;135:409-14.
5. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara J, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropema induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-70.
6. Gerhartz HH, Engelhard M, Meusers P, Brittinger G, Wilmanns W, Schlimok G, et al. Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 1993;82: 2329-39.
7. Gorin NC, Coiffier B, Hayat M, Fouillard L, Kuentz M, Flesch M, et al. Recombinant human granulocyte-macrophage colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind placebo-controlled trial. Blood 1992;80:1149-57.
8. Pettengell R, Gurney H, Radford JA, Deakin DP, James R, Wilkinson PM, et al Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood 1992;80:1430-6.
9. Biesma B, Vries EGE de, Willemse PHB, Sluiter WJ, Postmus PE, Limburg PC, et al. Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leucopenia and fever. Eur J Cancer 1992; 26:932-6.
10. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG, Levine AS, Deisseroth AB, et al. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 1979,67:194-200.
11. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia Am J Med 1982;72:101-11.
12. Hazenberg BPC, Leeuwen MA van, Rijswijk MH van, Stern AC, Vellenga E. Correction of granulocytopenia in Felty's syndrome by granulocyte-macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritis. Blood 1989;74:2769-70.
13. Riikonen P, Saarinen UM, Makipernaa A, Hovi L, Komulainen A, Pihkala J, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double blind placebo-controlled study in children. Pediatr Infect Dis J 1994;13:197-202.
14. Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, et al. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med 1994;121:492-501.
15. Mayordomo JI, Rivera F, Diaz-Puente MT, Lianes P, Colomer R, Lopez-Brea M, et al. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J Natl Cancer Inst 1995;87:803-8.